Concepedia

David M. Wilson

DM

184

Publications

14.8K

Citations

61

H-Index

1941

Active since

Affiliations

University of California, San Francisco(Current)

Keele University

University of St Andrews

Queen's University Belfast

University of Leicester

David M. Wilson is an author at University of California, San Francisco specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1941–2025

184

Publications

184

A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response

Laurens Kruidenier, Chun‐wa Chung, Zhongjun Cheng et al. · Nature · 2012 · 932 citations · Full text

, , +12

Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation

Huw D. Lewis, John Liddle, Jim Coote et al. · Nature Chemical Biology · 2015 · 717 citations · Full text

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers

Alex A. Adjei, Roger B. Cohen, Wilbur A. Franklin et al. · Journal of Clinical Oncology · 2008 · 572 citations · Full text

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia

Adriana E. Tron, Matthew A. Belmonte, Ammar Adam et al. · Nature Communications · 2018 · 479 citations · Full text

Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score

Rahul S. Desikan, Chun Chieh Fan, Yunpeng Wang et al. · PLoS Medicine · 2017 · 393 citations · Full text

Rows per page

1–5 of 184